Hormone replacement formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

IPC codes

A61K 31/56 (2006.01) A61J 1/00 (2006.01) A61K 9/24 (2006.01) A61K 31/00 (2006.01)

Type

Patent

Patent number

CA 2645320

Description

The basic formulation comprises a combination of three estrogens, 2-hydroxyestrone, 17-beta-estradiol and estriol, and a metabolite of an estrogen, 2-methoxyestradiol, in specified amounts. Amounts of folic acid, DHEA, testosterone, Vitamin B6, Di-Indolyl Methane, melatonin and progesterone, as well as selenium and cobalt can be added in specific amounts to the basic formulation. 2-Hydroxyestradiol, another metabolic, can also be added.

La formulation de base comprend une combinaison de trois AEstrogènes, la 2-hydroxyAEstrone, le 17-bêta-AEstradiol et l'AEstriol, et d'un métabolite d'un AEstrogène, le 2-méthoxyAEstradiol, en des quantités spécifiées. Des quantités d'acide folique, de DHEA, de testostérone, de vitamine B6, de diindolylméthane, de mélatonine et de progestérone, ainsi que de sélénium et de cobalt, peuvent être ajoutées dans des limites spécifiées à la formulation de base. Du 2-hydroxyAEstradiol, un autre métabolite, peut également être ajouté.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hormone replacement formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hormone replacement formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hormone replacement formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1990643

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.